Search

everythinglearnresearchcommunity

for

Search:↓

Scalp alopecia areata mostly affects young adult males, often starts suddenly, and usually presents as single, patchy lesions.

Oral clindamycin and rifampicin are the most effective treatments for Folliculitis decalvans.

Sulfasalazine might cause hair loss, especially in women, and stopping it can reverse the hair loss.

A woman's hair grew back while she was taking sulphasalazine for arthritis.

Migraines often worsen during perimenopause, but safe treatments are available.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

Premature hair graying is common and linked to stress, obesity, vitamin deficiencies, family history, lack of exercise, smoking, and allergies.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

Alopecia areata is significantly linked to thyroid issues and may worsen with diabetes severity.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

A new type of alopecia areata, called the "confetti variant," causes small bald spots that often heal on their own in a few months.

The combination treatment improved acne scars.

20% of patients with androgenic alopecia also had metabolic syndrome.

Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.

PRP is more effective than triamcinolone for treating alopecia areata.

The study concluded that key signs of Keratosis follicularis spinulosa decalvans are changes in terminal hair and vellus hair follicles, which likely start the inflammation and damage to hair follicles.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

Cosmetic products or emotional factors might contribute to Frontal Fibrosing Alopecia, and trichoscopy is useful for diagnosis.

About half of people with mild alopecia areata see hair regrowth in a year, but relapses are common.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

Hair disorders include hair loss, excessive hair growth, and ingrown hairs, with various treatments available depending on the cause.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

Stress can trigger and worsen vitiligo.

Younger people and those with existing acne are more likely to get folliculitis after hair restoration surgery, but it doesn't affect the overall good hair growth result.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Rash in SLE patients indicates more severe disease.

The document explains how to claim CME credit by diagnosing and treating hair loss conditions in two patient cases.

Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.